Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00120224 · ClinicalTrials.gov registry record
De-Medicalizing Mifepristone Medical Abortion
A clinical trial, sponsored by Gynuity Health Projects.
- Completed
- Registry status
- 4,410
- Enrollment target
NCT00120224 is a clinical trial that has completed, run by Gynuity Health Projects. The registered enrollment target is 4,410 participants.
The verdict
NCT00120224 has completed, sponsored by Gynuity Health Projects.
- COMPLETED
- Registry status
- 4,410 participants
- Enrollment target
Study Summary
This study will investigate the possibility that medical abortion using mifepristone and misoprostol - a safe, proven therapy for terminating early first trimester pregnancy - can be administered in a manner that is simpler and less costly than that routinely employed in the United States. The researchers hypothesize that: 1. Practitioners themselves, based on history and examination but without sonography, are able to dependably and correctly determine which patients are eligible for medical abortion and which patients either are not eligible or require further evaluation to determine eligibility. 2. Practitioners themselves, based on a symptom diary and low-sensitivity pregnancy test but without sonography, are able to dependably and correctly determine when a successful medical abortion has taken place and when referral for other possible outcomes should be made. 3. A symptom diary and low-sensitivity pregnancy test are safe and effective means of separating those women who could benefit from a follow-up visit from those who do not need one.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,410 participants |
| Start Date | 2005-05 |
| Est. Completion | 2007-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00120224
The ClinicalTrials.gov registry entry for NCT00120224 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,410 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynuity Health Projects, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00120224 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00120224 about?
NCT00120224 is a clinical study titled "De-Medicalizing Mifepristone Medical Abortion". This study will investigate the possibility that medical abortion using mifepristone and misoprostol - a safe, proven therapy for terminating early first trimester pregnancy - can be administered in a manner that is simpler and less costly than that routinely employed in the United States. The rese...
What is the current status of trial NCT00120224?
This trial is currently completed. The enrollment target is 4,410 participants. The study started on 2005-05. Estimated completion is 2007-04.
Who is sponsoring clinical trial NCT00120224?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.